|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 42.48 USD | -1.05% |
|
-0.61% | -13.31% |
| 07-01 | Samsung Bioepis Relaunches BYOOVIZ® (ranibizumab-nuna) in the United States in Partnership with Harrow | CI |
| 07-01 | Harrow Announces Commercial Launch of BYOOVIZ In The United States | CI |
| Market Cap | 1.58B 1.39B 1.28B 1.18B 2.24B 151B 2.28B 15.26B 5.99B 74.4B 5.95B 5.82B 256B | P/E 2026 * |
172x | P/E 2027 * | 18.4x |
|---|---|---|---|---|---|
| Enterprise Value | 1.58B 1.39B 1.28B 1.18B 2.24B 151B 2.28B 15.26B 5.99B 74.4B 5.95B 5.82B 256B | EV / Sales 2026 * |
4.55x | EV / Sales 2027 * | 3.07x |
| Free-Float |
84.53% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Harrow, Inc.
| 1 day | -1.05% | ||
| 1 week | -0.61% | ||
| Current month | +0.02% | ||
| 1 month | +12.83% | ||
| 3 months | +18.23% | ||
| 6 months | -9.19% | ||
| Current year | -13.31% |
| 1 week | 41.25 |  | 46.62 |
| 1 month | 37.86 | | 46.62 |
| Current year | 28.54 | | 54.85 |
| 1 year | 28.54 | | 54.85 |
| 3 years | 7.6 | | 59.23 |
| 5 years | 5.4 | | 59.23 |
| 10 years | 1.35 | | 59.23 |
| Manager | Title | Age | Since |
|---|---|---|---|
Mark Baum
CEO | Chief Executive Officer | 53 | 2011-12-16 |
Andrew Boll
PSD | President | 43 | 2025-08-20 |
Brett Burrell
CMP | Compliance Officer | - | 2023-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Mark Baum
CHM | Chairman | 53 | 2021-08-18 |
Perry Sternberg
BRD | Director/Board Member | 57 | 2022-03-30 |
Adrienne Graves
BRD | Director/Board Member | 71 | 2024-01-25 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-17 | Free | Director | 5,248 | 0.0141% | ||
| 06-17 | Free | Director | 5,248 | 0.0141% | ||
| 06-17 | Free | Director | 5,248 | 0.0141% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.05% | -0.61% | +21.61% | +130.74% | 1.58B | |
| -2.33% | -2.09% | +49.88% | +170.51% | 1,060B | |
| -0.82% | -2.30% | +63.79% | +62.00% | 619B | |
| -0.73% | -4.98% | +28.91% | +82.99% | 438B | |
| +0.33% | -1.17% | +31.07% | +27.09% | 333B | |
| -0.02% | -2.85% | +29.15% | +45.24% | 282B | |
| -3.89% | -11.22% | +22.81% | +27.30% | 267B | |
| +0.66% | -1.42% | -26.59% | -37.71% | 218B | |
| -0.06% | -2.88% | +23.07% | +62.33% | 196B | |
| -3.72% | -1.10% | +18.41% | +70.56% | 161B | |
| Average | -1.16% | -2.88% | +26.21% | +64.10% | 357.55B | |
| Weighted average by Cap. | -1.31% | -2.96% | +36.74% | +83.93% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 348M 305M 281M 260M 493M 33.22B 501M 3.36B 1.32B 16.37B 1.31B 1.28B 56.27B | 516M 451M 416M 384M 729M 49.18B 741M 4.97B 1.95B 24.23B 1.94B 1.89B 83.28B |
| Net income | 9.76M 8.54M 7.87M 7.27M 13.8M 931M 14.03M 94.09M 36.95M 459M 36.65M 35.85M 1.58B | 92.89M 81.25M 74.94M 69.22M 131M 8.86B 134M 895M 352M 4.36B 349M 341M 15B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-10 | US$42.48 | -1.05% | 411,359 |
| 26-07-09 | US$42.93 | -4.75% | 540,105 |
| 26-07-08 | US$45.07 | -2.34% | 534,030 |
| 26-07-07 | US$46.15 | +2.72% | 802,535 |
| 26-07-06 | US$44.93 | +5.12% | 949,421 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- HROW Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
